Osmic acid synovectomy in the era of biologics.
Slobodin
Gleb
G
Department of Internal Medicine, Bnai Zion Medical Center and Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel. gslobodin@yahoo.com
Rosner
Itzhak
I
Boulman
Nina
N
Rozenbaum
Michael
M
D000368:Aged; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001688:Biological Products / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007270:Injections, Intra-Articular; D007719:Knee Joint; D008297:Male; D008875:Middle Aged; D009993:Osmium Tetroxide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D012074:Remission Induction; D011795:Surveys and Questionnaires; D000074402:Synovectomy; D013997:Time Factors; D016896:Treatment Outcome